InvestSMART

ORDINARY FULLY PAID (ASX: OPT) - Announcements

DELISTED - Current share price for OPT : $0.013

ASX company news and announcements for ORDINARY FULLY PAID (OPT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ORDINARY FULLY PAID (OPT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ORDINARY FULLY PAID (OPT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ORDINARY FULLY PAID (OPT)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$18 Opthea to Present at 43rd J.P. Morgan Healthcare Conference 19 Dec 2024 8:38AM $0.650 $0.013 fallen by 98%
$18 Change of Director's Interest Notice - SS 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice - SO 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice - QO 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice - LG 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice - JH 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice -AT 17 Dec 2024 8:17AM $0.635 $0.013 fallen by 97.95%
$18 Change of Director's Interest Notice - JL 17 Dec 2024 8:16AM $0.635 $0.013 fallen by 97.95%
$18 Notification regarding unquoted securities - OPT 16 Dec 2024 10:37AM $0.623 $0.013 fallen by 97.91%
$18 Notification regarding unquoted securities - OPT 16 Dec 2024 10:01AM $0.630 $0.013 fallen by 97.94%
$18 Notification regarding unquoted securities - OPT 16 Dec 2024 9:58AM $0.630 $0.013 fallen by 97.94%
$18 Notification regarding unquoted securities - OPT 16 Dec 2024 9:49AM $0.630 $0.013 fallen by 97.94%
$18 Opthea's Wet AMD Program to be Featured at FLORetina 2024 26 Nov 2024 8:23AM $0.610 $0.013 fallen by 97.87%
$18 Opthea Participate in Citi 2024 Global Healthcare Conference 25 Nov 2024 9:49AM $0.605 $0.013 fallen by 97.85%
$18 Initial Director's Interest Notice 15 Nov 2024 12:57PM $0.650 $0.013 fallen by 98%
$18 Opthea Received A$15.9 Million R&D Tax Incentive 15 Nov 2024 10:24AM $0.660 $0.013 fallen by 98.03%
$18 Results of Meeting 15 Nov 2024 10:22AM $0.660 $0.013 fallen by 98.03%
$18 Director Appointment/Resignation 15 Nov 2024 9:37AM $0.700 $0.013 fallen by 98.14%
$18 Chair's Address to Shareholders 15 Nov 2024 9:34AM $0.700 $0.013 fallen by 98.14%
$18 Opthea's Wet AMD Program Featured at Ophthalmology Events 12 Nov 2024 8:45AM $0.820 $0.013 fallen by 98.41%
$18 Update Opthea Participates in November Investor Conferences 4 Nov 2024 11:33AM $0.808 $0.013 fallen by 98.39%
$18 Opthea to Participate in November Investor Conferences 4 Nov 2024 8:25AM $0.800 $0.013 fallen by 98.38%
$18 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 8:23AM $0.840 $0.013 fallen by 98.45%
$18 Opthea Corporate Presentation - Oct 2024 28 Oct 2024 8:26AM $0.825 $0.013 fallen by 98.42%
$18 Notice of Annual General Meeting/Proxy Form 16 Oct 2024 10:02AM $0.915 $0.013 fallen by 98.58%

101 - 125 of 733 results

Page 5 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.